SCHOTT Pharma

This is a new category for 2024. And you voted for Schott Pharma – and its portfolio packed with prefillable syringes, cartridges, vials, ampoules, analytical development services, and other solutions in containment and drug delivery. On average, more than 25,000 patients every minute receive an injection stored in a Schott Pharma product. The company manufactures solutions made out of borosilicate glass or high-grade pharmaceutical COC polymer. In 2022, Schott Pharma was carved-out from Schott AG – which dates back more than 130 years – to when Otto Schott set out to innovate in the world of glass.

In September 2023, the company made its debut on the Frankfurt stock exchange. And 2024 started with a bang for the company; in January, the company released its first sustainability report, launched a new range of vials for deep-cold temperature applications like mRNA and gene therapy, and reported 2023 revenues up by 9 percent compared with the previous year.